Navigation Links
Now Available in South Florida: CentraSight Treatment Program Offers New Hope for Patients with End-Stage Macular Degeneration
Date:2/13/2013

FORT LAUDERDALE, Fla., Feb. 13, 2013 /PRNewswire/ -- The CentraSight™ treatment program, now available at Retina Associates of Miami in South Florida, features the first-ever FDA-approved telescope implant surgical option for patients with End-Stage Age-related Macular Degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.

(Photo: http://photos.prnewswire.com/prnh/20130213/LA59823)

Smaller than a pea, the telescope implant uses micro-optical technology to magnify images which would normally be seen in one's "straight ahead," or central, vision. The images are projected onto the healthy portion of the retina not affected by the disease.

The telescope implant has been demonstrated in clinical trials to improve quality of life for those with central vision loss in both eyes. It improves patients' vision and returns things most of us take for granted. People regain the ability to see the things that are important to them, increase their independence, and re-engage in everyday activities. They can once again recognize faces and see expressions.

The telescope implant is not a cure for end-stage AMD. As with any medical intervention, potential risks and complications exist with the telescope implant. Possible side effects include decreased vision or vision-impairing corneal swelling.

The first CentraSight Patient Treatment Program team in South Florida includes Dr. J. Harris Levy , MD, Dr. Rashid M. Taher , MD, and Wilfredo C. Lara , MD, who evaluate the patient's medical condition for eligibility certification; Dr. Jesse Pelletier , MD, who performs the implant surgery; and Dr. Marc J. Gannon , OD, FAOO, the low vision specialist who evaluates the patient's visual function and coordinates the post-surgical therapy.

To schedule an evaluation contact Dr. Marc Gannon at 866-942-2020.
Visit www.lowvisioninstitute.com for more information.

About CentraSight
CentraSight is the first-ever telescope implant for end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans.  Patients with end-stage AMD have a central blind spot or missing area in their vision that makes it difficult or impossible to see faces, read, and perform everyday activities. The CentraSight Treatment Program allows patients to see again by implanting a tiny telescope in the eye in an outpatient procedure, then coordinating with vision specialists to help the patient learn how to use their new vision for everyday activities. For more information visit http://www.centrasight.com/

About Macular Degeneration
More than 15 million Americans are affected by some form of AMD. This number is expected to double by the year 2050.

  • Patients who progress to the end-stage form of AMD have a central blind spot that makes it difficult or impossible for patients to perform everyday activities such as reading, watching TV, preparing meals, and self-care.
  • Macular degeneration attacks the macula, the region of the retina responsible for central, detailed vision. It robs the individual of their central, straight-ahead vision, resulting in what is often referred to as a central vision "blind spot." It does not affect the outer circle of peripheral vision. People see things to the side, but it is too blurry to make up for lost central vision.
  • First signs of AMD: straight lines may appear wavy or disconnected; when looking at a person's face, it is blurred while the rest of the person is in focus; lines of print may be blurred in the center or the lines may be crooked.

CONTACT: Jackie Goldstein
jackieflashgoldstein@gmail.com 
954.849.7971


'/>"/>
SOURCE Retina Associates of Miami
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Inovio Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
4. Last Minute Batch of Flu Shots made Available for Free At Naperville and Arlington Heights Immediate Care Centers
5. Raleigh CoolSculpting Complete Provides Twice the Fat Elimination in Just One Hour Now Available at Michael Law MD Aesthetic Plastic Surgery
6. Phase 3 Topical Drug for Raynauds Disease Available for Licensing/Acquisition at the J.P. Morgan Conference
7. Now Available in Fredericksburg: Painless Screening Exam To Help Prevent Heart Attacks, Strokes
8. The First Lean Healthcare App is Now Available in Apples App Store
9. Fuse Science, Inc. DROPS Now Available at PoweredByFuse.com
10. Vicks Starry Night Humidifier Available Now in New Colors Exclusively at Babies"R"Us
11. New Treatment For Obstructive Sleep Apnea Now Available In Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... -- Summary This report provides all ... its partnering interests and activities since 2010. Description The ... insight into the partnering activity of one of the world,s ... are prepared upon purchase to ensure inclusion of the most ... report will be delivered in PDF format within 1 working ...
(Date:3/27/2017)... Calif. , March 27, 2017  Cryoport, Inc. ... that it intends to offer shares of common stock ... registration statement on file with the Securities and Exchange ... and other conditions, and there can be no assurance ... completed, or as to the actual size or terms ...
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, ... by Ethicon, a division of Johnson & Johnson. Torax ... for the treatment of gastro-esophageal reflux disease (GERD). ... augmentation (MSA) technology and the procedure is currently ... Torax Medical was founded by Sanderling ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, ... of few medical professionals in the country to sit on the 2017 National Advisory ... in just 2 years Dr. Harper helped propel the clinic from a small start-up ...
(Date:3/28/2017)... ... 28, 2017 , ... AutismOne announced the Board Certified in ... Medicine and available for application on Saturday, May 27, 2017, following Thursday, Friday, ... Springs. , Ed Arranga, president of AutismOne, stated: "Many of the modalities termed ...
(Date:3/28/2017)... ... March 28, 2017 , ... Public relations pros work hard to ... of business channels. , While many results are clear, much of PR is hard ... , When it comes to measurement, firms should always take an all-inclusive approach that ...
(Date:3/28/2017)... ... ... With expansion and efficiency in mind, Patten Seed Company completed relocation of ... opened in Marshallville in 2006, and a bagging and shipping facility has been in ... Patten Seed operations to the Middle Georgia location from their previous home in Lakeland, ...
Breaking Medicine News(10 mins):